Security key
88025U109
10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (TXG)
CUSIP: 88025U109
Q1 2020 13F Holders as of 31 Mar 2020
- Security type / class
- Equity / Class A Common Stock, $0.00001 par value per share
- Total 13F shares
- 38,929,050
- Total 13F value
- $2,426,163,019
- Share change
- +9,920,888
- Put/Call ratio
- 48%
- SEC-reported price per share
- $62.32
- Number of holders
- 102
- Value change
- +$612,574,707
- Number of buys
- 68
- Number of sells
- 30
- Shares outstanding
- 120,172,375
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2020
Institutions
102
Top holders
10
TXG full security history
Ownership snapshot
Full 13F holder table
10x Genomics, Inc. SEC filings
10x Genomics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of TXG - 10x Genomics, Inc. - Class A Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Foresite Capital Manageme...
Disclosed value leader
Foresite Capital Manageme...
Comparable rows
0/15
Latest evidence
31 Dec 2019
13F
Highest disclosed value: $551,699,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Foresite Capital Management I, LLC has the largest disclosed position value at $551.7M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Foresite Capital Management I, LLC's linked filing trail.
Disclosed position value
Top 5
Foresite Capital Management I, LLC
$551.7M
Foresite Capital Management II, LLC
$521.34M
FMR LLC
$239.05M
VHCP Management II, LLC
$136.22M
JS Capital Management LLC
$127.7M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Foresite Capital Management I, LLC |
13F
Company
|
—
denominator unverified
|
$551,699,000
7,235,396 shares
|
— | 31 Dec 2019 |
| Foresite Capital Management II, LLC |
13F
Company
|
—
denominator unverified
|
$521,341,000
6,837,253 shares
|
— | 31 Dec 2019 |
| FMR LLC |
13F
Company
|
—
denominator unverified
|
$239,049,000
3,135,078 shares
|
— | 31 Dec 2019 |
| VHCP Management II, LLC |
13F
Company
|
—
denominator unverified
|
$136,215,000
1,786,431 shares
|
— | 31 Dec 2019 |
| JS Capital Management LLC |
13F
Company
|
—
denominator unverified
|
$127,702,000
1,674,780 shares
|
— | 31 Dec 2019 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$83,144,000
1,090,410 shares
|
— | 31 Dec 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2020
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
102
Shares
38,929,050
Rows available
102
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2020 vs Q1 2020 Across Filers
Q1 2020 holders
102
Q1 2020 holders
102
Holder diff
0
| Investor | Q1 2020 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q1 2020 value | Q1 2020 value | Value change | Value Chg % |
|---|